Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ADB International Group Inc. (EQUR : OTC)
 
 • Company Description   
E-Qure Corp. is a medical device manufacturer and distributor. It is focused on the development and commercialization of bioelectrical signal therapy (BST) devices primarily in the United States. The Company's BST device uses patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. E-Qure Corp., formerly known as ADB International Group, Inc., is based in New York.

Number of Employees: 1

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.03 Daily Weekly Monthly
20 Day Moving Average: 2,988 shares
Shares Outstanding: (millions)
Market Capitalization: $ (millions)
Beta: 1.52
52 Week High: $0.07
52 Week Low: $0.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -28.13% -19.06%
12 Week -17.86% -9.70%
Year To Date 176.00% 237.23%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
20 WEST 64TH STREET SUITE 39G
-
NEW YORK,NY 10023
USA
ph: 972-5442-7777
fax: 972-8916-7331
None http://www.e-qure.com
 
 • General Corporate Information   
Officers
Ohad Goren - Chief Executive Officer and director
Ron Weissberg - Chairman
Gal Peleg - Chief Financial Officer
Itsik Ben Yesha - Chief Technology Officer and director
Michael Sessler - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 26885P109
SIC: 5090
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 07/05/22
Share - Related Items
Shares Outstanding:
Most Recent Split Date: 8.00 (0.01:1)
Beta: 1.52
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/05/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 100.00%
vs. Previous Quarter: 100.00%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -2,307.05
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - 0.02
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - 0.02
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©